The biology of interleukin-1: Emerging concepts in the regulation of the actin cytoskeleton and cell junction dynamics

Cellular and Molecular Life Sciences

Volumn 69, Issue 4, 2012, Pages 487-500

  Lie, Pearl P Y ^a   Yan Cheng, C ^a   Mruk, Dolores D ^a  

^a POPULATION COUNCIL   (United States)

Author keywords

Actin cytoskeleton; Cell junction; Cytokine; Interleukin; Sertoli cell; Testis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 1BETA; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ACTIN FILAMENT; AUTOCRINE EFFECT; BLOOD TESTIS BARRIER; CELL ADHESION; CELL JUNCTION; HUMAN; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEMINIFEROUS TUBULE; SERTOLI CELL; SIGNAL TRANSDUCTION; SPERMATOGENESIS; TISSUE METABOLISM;

ACTIN CYTOSKELETON; HUMANS; INTERCELLULAR JUNCTIONS; INTERLEUKIN-1; NF-KAPPA B; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; SPERMATOGENESIS;

EID: 84857062958     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-011-0760-0     Document Type: Review

References (149)

1. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550
2. Dinarello CA (2006) Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 83:447S-455S (Pubitemid 44713217)
3. Lomedico PT, Gubler U, Hellmann CP, Dukovich M, Giri JG, Pan YE, Collier K, Semionow R, Chua AO, Mizel SB (1984) Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312:458-462
4. Auron PE, Webb AC, Rosenwasser LJ, Mucci SF, Rich A, Wolff SM, Dinarello CA (1984) Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA 81:7907-7911 (Pubitemid 15169171)
5. Schmitz J,OwyangA,OldhamE, SongY,Murphy E,McClanahan TK, Zurawski G,Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479-490 (Pubitemid 41587888)
6. Dinarello CA (2005) Blocking IL-1 in systemic inflammation. J Exp Med 201:1355-1359 (Pubitemid 40664079)
7. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, Anderson JP, Wanderer AA, Firestein GS (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364:1779-1785 (Pubitemid 39488063)
8. Maier JA, Voulalas P, Roeder D, Maciag T (1990) Extension of the life-span of human endothelial cells by an interleukin-1a antisense oligomer. Science 249:1570-1574
9. Corradi A, Franzi AT, Rubartelli A (1995) Synthesis and secretion of interleukin-1a and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes. Exp Cell Res 217:355-362
10. Walsh SV, Hopkins AM, Nusrat A (2000) Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev 41:303-313 (Pubitemid 30347380)
11. Harhaj NS, Antonetti DA (2004) Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36:1206-1237 (Pubitemid 38519069)
12. Sarkar O, Mathur PP, Cheng CY, Mruk DD (2008) Interleukin 1a (IL1A) is a novel regulator of the blood-testis barrier in the rat. Biol Reprod 78:445-454 (Pubitemid 351416480)
13. Lie PPY, Cheng CY, Mruk DD (2011) Interleukin-1a is a regulator of the blood-testis barrier. FASEB J 25:1244-1253
14. March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K, Conlon PJ, Hopp TP, Cosman D (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641-647 (Pubitemid 15232875)
15. Dinarello CA (1997) Interleukin-1. Cytokine Growth Factor Rev 8:253-265 (Pubitemid 28201653)
16. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:2095-2147 (Pubitemid 26086851)
17. Mosley B, Urdal DL, Prickett KS, Larsen A, Cosman D, Conlon PJ, Gillis S, Dower SK (1987) The interleukin-1 receptor binds the human interleukin-1a precursor but not the interleukin-1b precursor. J Biol Chem 262:2941-2944 (Pubitemid 17127537)
18. Kobayashi Y, Yamamoto K, Saido T, Kawasaki H, Oppenheim JJ, Matsushima K (1990) Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1a. Proc Natl Acad Sci USA 87:5548-5552
19. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J et al (1992) A novel heterodimeric cysteine protease is required for interleukin-1b processing in monocytes. Nature 356:768-774
20. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, Flavell RA (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1b converting enzyme. Science 267:2000-2003
21. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardwell S, Wei FY, Wong W, Kamen R, Seshadri T (1995) Mice deficient in IL-1b-converting enzyme are defective in production of mature IL-1b and resistant to endotoxic shock. Cell 80:401-411
22. Rubartelli A, Cozzolino F, Talio M, Sitia R (1990) A novel secretory pathway for interleukin-1b, a protein lacking a signal sequence. EMBO J 9:1503-1510
23. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-b. Mol Cell 10:417-426 (Pubitemid 35007355)
24. Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229-265
25. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, Di Virgilio F (2006) The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176:3877-3883 (Pubitemid 44264361)
26. Mariathasan S, Monack DM (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7:31-40 (Pubitemid 46020825)
27. Martinon F, Tschopp J (2007) Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14:10-22 (Pubitemid 44911890)
28. Skaper SD, Debetto P, Giusti P (2010) The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J 24:337-345
29. Khakh BS, North RA (2006) P2X receptors as cell-surface ATP sensors in health and disease. Nature 442:527-532 (Pubitemid 44167906)
30. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, Griffiths RJ, Gabel CA (2001) Altered cytokine production in mice lacking P2X7 receptors. J Biol Chem 276:125-132 (Pubitemid 32050297)
31. Humphreys BD, Rice J, Kertesy SB, Dubyak GR (2000) Stressactivated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J Biol Chem 275:26792-26798
32. Aga M, Johnson CJ, Hart AP, Guadarrama AG, Suresh M, Svaren J, Bertics PJ, Darien BJ (2002) Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X7. J Leukoc Biol 72:222-232
33. Potucek YD, Crain JM, Watters JJ (2006) Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression. Neurochem Int 49:204-214 (Pubitemid 43867079)
34. Andrei C, Margiocco P, Poggi A, Lotti LV, Torrisi MR, Rubartelli A (2004) Phospholipases C and A2 control lysosomemediated IL-1b secretion: implications for inflammatory processes. Proc Natl Acad Sci USA 101:9745-9750 (Pubitemid 38869307)
35. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A (2001) Rapid secretion of interleukin-1b by microvesicle shedding. Immunity 8:825-835 (Pubitemid 34008509)
36. Chen C, Kono H, Golenbock D, Reed G, Akira S, Rock KL (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13:851-856 (Pubitemid 47038190)
37. Dinarello CA (1994) The interleukin-1 family: 10 years of discovery. FASEB J 8:1314-1325
38. Gustafsson K, Sultana T, Zetterstrom CK, Setchell BP, Siddiqui A, Weber G, Soder O (2002) Production and secretion of interleukin-1a proteins by rat testis. Biochem Biophys Res Commun 297:492-497
39. O'Neill LAJ (2008) The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 226:10-18
40. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475 (Pubitemid 23276556)
41. Mantovani A, Locati M, Polentarutti N, Vecchi A, Garlanda C (2004) Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR. J Leukoc Biol 75:738-742 (Pubitemid 38580052)
42. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G (1995) Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 270:13757-13765
43. Lang D, Knop J, Wesche H, Raffetseder U, Kurrle R, Boraschi D, Martin MU (1998) The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol 161:6871-6877 (Pubitemid 28562232)
44. Dunne A, O'Neill LAJ (2003) The interleukin-1 receptor/Tolllike receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 171:re3-re17
45. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, Di Marco F, French L, Tschopp J (1998) MyD88, an adaptor protein involved in interleukin-1 signaling. J Biol Chem 273:12203-12209 (Pubitemid 28240584)
46. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z (1997) MyD88: an adaptor that recruits IRAK to the IL-1 receptor complex. Immunity 7:837-847 (Pubitemid 28064897)
47. Wang Z, Wesche H, Stevens T, Walker N, Yeh WC (2009) IRAK-4 inhibitors for inflammation. Curr Top Med Chem 9:724-737
48. Gottipati S, Rao NL, Fung-Leung WP (2008) IRAK1: a critical signaling mediator of innate immunity. Cell Signal 20:269-276
49. Janssens S, Beyaert R (2003) Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell 11:293-302 (Pubitemid 36293825)
50. Suzuki N, Suzuki S, Yeh WC (2002) IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol 23:503-506 (Pubitemid 35248046)
51. Barton GM, Medzhitov R (2003) Toll-like receptor signaling pathways. Science 300:1524-2525
52. Kawaguchi Y, Nishimagi E, Tochimoto A, Kawamoto M, Katsumata Y, Soejima M, Kanno T, Kamatani N, Hara M (2006) Intracellular IL-1a-binding proteins contribute to biological functions of endogenous IL-1a in system sclerosis fibroblasts. Proc Natl Acad Sci USA 103:14501-14506 (Pubitemid 44484779)
53. Maier JAM, Statuto M, Ragnotti G (1994) Endogenous interleukin 1a must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol 14:1845-1851 (Pubitemid 24074579)
54. Wessendorf JHM, Garfinkel S, Zhan X, Brown S, Maciag T (1993) Identification of a nuclear localization sequence within the structure of the human interleukin-1a precursor. J Biol Chem 268:22100-22104 (Pubitemid 23320721)
55. Hu B, Wang S, Zhang Y, Feghali CA, Dingman JR, Wright TM (2003) A nuclear target for interleukin-1a: interaction with the growth suppressor necdin modulates proliferation and collagen expression. Proc Natl Acad Sci USA 100:10008-10013 (Pubitemid 37087059)
56. Luheshi NM, Rothwell NJ, Brough D (2009) The dynamics and mechanisms of interleukin-1a and b nuclear import. Traffic 10:16-25
57. Fadeel B, Grzybowska E (2009) HAX-1: a multifunctional protein with emerging roles in human disease. Biochim Biophys Acta 1790:1139-1148
58. Yin HL, Morioka H, Towle CA, Vidal M, Watanabe T, Weissbach L (2001) Evidence that HAX-1 is an interleukin-1a N-terminal binding protein. Cytokine 15:122-137 (Pubitemid 34587494)
59. Kawaguchi Y, McCarthy SA, Watkins SC, Wright TM (2004) Autocrine activation by interleukin 1a induces the fibrogenic phenotype of systemic sclerosis fibroblasts. J Rheumatol 31:1946-1954 (Pubitemid 39336718)
60. Campos SB, Ashworth SL, Wean S, Hosford M, Sandoval RM, Hallett M.A., Atkinson SJ, Molitoris BA (2009) Cytokineinduced F-actin reorganization in endothelial cells involves RhoA activation. Am J Physiol Renal Physiol 296:F487-F495
61. Nilsson M, Husmark J, Bjorkman U, Ericson LE (1998) Cytokines and thyroid epithelial integrity: interleukin-1a induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes. J Clin Endocrinol Metab 83:945-952 (Pubitemid 28496474)
62. Al-Sadi RM, Ma TY (2007) IL-1b causes an increase in intestinal epithelial tight junction permeability. J Immunol 178:4641-4649 (Pubitemid 46492417)
63. Quagliarello VJ, Wispelwey B, Long WJ, Scheld WM (1991) Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. J Clin Invest 87:1360-1366
64. Singh R, Wang B, Shirvaikar A, Khan S, Kamat S, Schelling JR, Konieczkowski M, Sedor JR (1999) The IL-1 receptor and Rho directly associate to drive cell activation and inflammation. J Clin Invest 103:1561-1570
65. Ridley AJ (2006) Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16:522-529 (Pubitemid 44444995)
66. Heasman SJ, Ridley AJ (2008) Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9:690-701
67. Burridge K, Wennerberg K (2004) Rho and Rac take center stage. Cell 116:167-179 (Pubitemid 38167310)
68. Jaffe AB, Hall A (2005) Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21:247-269 (Pubitemid 41740635)
69. Bishop AL, Hall A (2000) Rho GTPases and their effector proteins. Biochem J 348:241-255 (Pubitemid 30345195)
70. Barth BM, Stewart-Smeets S, Kuhn TB (2009) Proinflammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase. Mol Cell Neurosci 41:274-285
71. Ridley AJ, Hall A (1992) The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399
72. Quarnstrom EE, Page RC, Gillis S, Dower SK (1988) Binding, internalization, and intracellular localization of interleukin-1b in human diploid fibroblasts. J Biol Chem 263:8261-8269
73. Wang Q, Downey GP, Herrera-Abreu MT, Kapus A, McCulloch CA (2005) SHP-2 modulates interleukin-1-induced Ca2? flux and ERK activation via phosphorylation of phospholipase Cc1. J Biol Chem 280:8397-8406 (Pubitemid 40349744)
74. Ganter MT, Roux J, Miyazawa B, Howard M, Frank JA, Su G, Sheppard D, Violette SM, Weinreb PH, Horan GS, Matthay MA, Pittet J (2008) Interleukin-1b causes acute lung injury via avb5 and avb6 integrin-dependent mechanisms. Circ Res 102:804-812 (Pubitemid 351521585)
75. Summers L, Kangwantas K, Nguyen L, Kielty C, Pinteaux E (2010) Adhesion to the extracellular matrix is required for interleukin-1b actions leading to reactive phenotype in rat astrocytes. Mol Cell Neurosci 44:272-281
76. Novakofski K, Boehm A, Fortier L (2009) The small GTPase Rho mediates articular chondrocyte phenotype and morphology in response to interleukin-1a and insulin-like growth factor-I. J Orth Res 27:58-64
77. Chrzanowska-Wodnicka M, Burridge K (1996) Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 133:1403-1415 (Pubitemid 26192339)
78. Pittet J, Griffiths MJD, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LAS, Gotwals PJ, Koteliansky VE, Matthay MA, Sheppard D (2001) TGF-b is a critical mediator of acute lung injury. J Clin Invest 107:1537-1544 (Pubitemid 32574640)
79. Lui WY, Lee WM, Cheng CY (2003) Transforming growth factor-b3 regulates the dynamics of Sertoli cell tight junctions via the p38 mitogen-activated protein kinase pathway. Biol Reprod 68:1597-1612 (Pubitemid 36519763)
80. Baker RG, Hayden MS, Ghosh S (2011) NF-jB, inflammation and metabolic disease. Cell Metab 13:11-22
81. Schneider G, Kramer OH (2011) NF-jB/p53 crosstalk-a promising new therapeutic target. Biochim Biophys Acta 1815:90-103
82. Tak PP, Firestein GS (2001) NF-jB: a key role in inflammatory diseases. J Clin Invest 107:7-11 (Pubitemid 32047405)
83. Aggarwai BB (2004) Nuclear factor-jB: the enemy within. Cancer Cell 6:203-208
84. Al-Sadi R, Ye D, Said HM, Ma TY (2010) IL-1b-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-jB pathway. Am J Pathol 177:2310-2322
85. Al-Sadi R, Ye D, Dokladny K, Ma TY (2008) Mechanism of IL-1b-induced increase in intestinal epithelial tight junction permeability. J Immunol 180:5653-5661
86. Kamm KE, Stull JT (2001) Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 276:4527-4530
87. Shen Q, Rigor RR, Pivetti CD, Wu MH, Yuan SY (2010) Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc Res 87:272-280
88. Ivanov AI, Parkos CA, Nusrat A (2010) Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol 177:512-524
89. Kumar S, Millis JT, Baglioni C (1992) Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts. Proc Natl Acad Sci USA 89:4683-4687
90. Dewberry RM, Crossman DC, Francis SE (2003) Interleukin-1 receptor antagonist (IL-1RN) genotype modulates the replicative capacity of human endothelial cells. Circ Res 92:1285-1287 (Pubitemid 36773469)
91. Maas-Szabowski N, Fusenig NE (1996) Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol 107:849-855 (Pubitemid 26408203)
92. Barland CO, Zettersten E, Brown BS, Ye J, Elias PM, Ghadially R (2004) Imiquimod-induced interleukin-1a stimulation improves barrier homeostasis in aged murine epidermis. J Invest Dermatol 122:330-336 (Pubitemid 38281052)
93. Ye J, Garg A, Calhoun C, Feingold KR, Elias PM, Ghadially R (2002) Alterations in cytokine regulation in aged epidermis: implications for permeability barrier homeostasis and inflammation. I. IL-1 gene family. Exp Dermatol 11:209-216 (Pubitemid 36934650)
94. Clermont Y (1972) Kinetics of spermatogenesis in mammals: seminiferous epithelium cycle and spermatogonial renewal. Physiol Rev 52:198-235
95. Lie PPY, Cheng CY, Mruk DD (2011) The biology of the desmosome-like junction: a versatile anchoring junction and signal transducer in the seminiferous epithelium. Int Rev Cell Mol Biol 286:223-269
96. Wong EWP, Cheng CY (2009) Polarity proteins and cell-cell interactions in the testis. Int Rev Cell Mol Biol 278:309-353
97. Bardin CW, Cheng CY, Musto NA, Gunsalus GL (1988) The Sertoli cell. In Knobil E, Neill JD, Ewing LL, Greenwald GS, Markert CL, Pfaff DW (eds) The physiology of reproduction, vol 1. Raven Press, New York, pp 933-974
98. Mruk DD, Cheng CY (2004) Sertoli-Sertoli and Sertoli-germ cell interactions and their significance in germ cell movement in the seminiferous epithelium during spermatogenesis. Endocr Rev 25:747-806 (Pubitemid 39362296)
99. Cheng CY, Mruk DD (2002) Cell junction dynamics in the testis: Sertoli-germ cell interactions and male contraceptive development. Physiol Rev 82:825-874
100. Russell LD (1977) Movement of spermatocytes from the basal to the adluminal compartment of the rat testis. Am J Anat 148:313-328
101. Parvinen M (1982) Regulation of the seminiferous epithelium. Endocr Rev 3:404-417
102. Cheng CY, Mruk DD (2009) An intracellular trafficking pathway in the seminiferous epithelium regulating spermatogenesis: a biochemical and molecular perspective. Crit Rev Biochem Mol Biol 44:245-263
103. Lie PPY, Cheng CY, Mruk DD (2009) Coordinating cellular events during spermatogenesis: a biochemical model. Trends Biochem Sci 34:366-373
104. Cheng CY, Mruk DD (2010) A local autocrine axis in the testes that regulates spermatogenesis. Nat Rev Endocrinol 6:380-395
105. O'Donnell L, Nicholls OK, O'Bryan MK, McLachlan RI, Stanton PG (2011) Spermiation: the process of sperm release. Spermatogenesis 1:14-35
106. Li MWM, Mruk DD, Lee WM, Cheng CY (2009) Cytokines and junction restructuring events during spermatogenesis in the testis: an emerging concept of regulation. Cytokine Growth Factor Rev 20:329-338
107. Jonsson CK, Zetterstrom RH, Holst M, Parvinen M, Soder O (1999) Constitutive expression of interleukin-1a messenger ribonucleic acid in rat Sertoli cells is dependent upon interaction with germ cells. Endocrinology 140:3755-3761 (Pubitemid 30645432)
108. Gerard N, Syed V, Bardin W, Genetet N, Jegou B (1991) Sertoli cells are the site of interleukin-1a synthesis in rat testis. Mol Cell Endocrinol 82:R13-R16
109. Haugen TB, Landmark BF, Josefsen GM, Hansson V, Hogset A (1994) The mature form of interleukin-1a is constitutively expressed in immature male germ cells from rat. Mol Cell Endocrinol 105:R19-R23
110. Zeyse D, Lunenfeld E, Beck M, Prinsloo I, Huleihel M (2000) Interleukin-1 receptor antagonist is produced by Sertoli cells in vitro. Endocrinology 141:1521-1527 (Pubitemid 32269121)
111. Rozwadowska N, Fiszer D, Jedrzejczak P, Kosicki W, Kurpisz M (2007) Interleukin-1 superfamily genes expression in normal or impaired human spermatogenesis. Genes Immun 8:100-107 (Pubitemid 46390907)
112. Gomez E, Morel G, Cavalier A, Lienard M, Haour F, Courtens J, Jegou B (1997) Type I and type II interleukin-1 receptor expression in rat, mouse and human testes. Biol Reprod 56:1513-1526 (Pubitemid 27215460)
113. Sultana T, Svechnikov K, Weber G, Soder O (2000) Molecular cloning and expression of a functionally different alternative splice variant of pro-interleukin-1a from the rat testis. Endocrinology 141:4413-4418 (Pubitemid 32055115)
114. Janitz M, Fiszer D, Lukaszyk A, Skorupski W, Kurpisz M (1995) Analysis of mRNA expression for interleukin-1 genes on human testicular cells. Immunol Lett 48:139-143 (Pubitemid 26011530)
115. Syed V, Stephan J, Gerard N, Legrand A, Parvinen M, Bardin CW, Jegou B (1995) Residual bodies activate Sertoli cell interleukin-1a (IL-1a) release, which triggers IL-6 production by an autocrine mechanism, through the lipoxygenase pathway. Endocrinology 136:3070-3078
116. Wahab-Wahlgren A, Holst M, Ayele D, Sultana T, Parvinen M, Gustafsson K, Granholm T, Soder O (2000) Constitutive production of interleukin-1a mRNA and protein in the developing rat testis. Int J Androl 23:360-365
117. Gerard N, Syed V, Jegou B (1992) Lipopolysaccharide, latex beads and residual bodies are potent activators of Sertoli cell interleukin-1a production. Biochem Biophys Res Commun 185:154-161
118. Petersen C, Boitani C, Froysa B, Soder O (2002) Interleukin-1 is a potent growth factor for immature rat Sertoli cells. Mol Cell Endocrinol 186:37-47 (Pubitemid 34189777)
119. Petersen C, Svechnikov K, Froysa B, Soder O (2005) The p38 MAPK pathway mediates interleukin-1-induced Sertoli cell proliferation. Cytokine 32:51-59 (Pubitemid 41405784)
120. Pollanen P, Soder O, Parvinen M (1989) Interleukin-1a stimulation of spermatogonial proliferation in vivo. Reprod Fertil Dev 1:85-87 (Pubitemid 20125961)
121. Okuma Y, Saito K, O'Connor AE, Phillips DJ, de Kretser DM, Hedger MP (2005) Reciprocal regulation of activin A and inhibin B by interleukin-1 (IL-1) and follicle-stimulating hormone (FSH) in rat Sertoli cells in vitro. J Endocrinol 185:99-110 (Pubitemid 40585071)
122. Colon E, Svechnikov KV, Carlsson-Skwirut C, Bang P, Soder O (2005) Stimulation of steroidogenesis in immature rat Leydig cells evoked by interleukin-1a is potentiated by growth hormone and insulin-like growth factors. Endocrinology 146:221-230 (Pubitemid 40051743)
123. Bornstein SR, Rutkowski H, Vrezas I (2004) Cytokines and steroidogenesis. Mol Cell Endocrinol 215:135-141 (Pubitemid 38333252)
124. Calkins JH, Sigel MM, Nankin HR, Lin T (1988) Interleukin-1 inhibits Leydig cell steroidogenesis in primary culture. Endocrinology 123:1605-1610
125. Lui WY, LeeWM, Cheng CY (2001) Transforming growth factorb3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11. Endocrinology 142:1865-1877 (Pubitemid 32405944)
126. Li MWM, Xia W, Mruk DD, Wang CQF, Yan HHN, Siu MKY, Lui WY, Lee WM, Cheng CY (2006) Tumor necrosis factor a reversibly disrupts the blood-testis barrier and impairs Sertoli-germ cell adhesion in the seminiferous epithelium of adult rat testes. J Endocrinol 190:313-329 (Pubitemid 44288369)
127. Lie PPY, Mruk DD, Lee WM, Cheng CY (2009) Epidermal growth factor receptor pathway substrate 8 (Eps8) is a novel regulator of cell adhesion and the blood-testis barrier integrity in the seminiferous epithelium. FASEB J 23:2555-2567
128. Lie PPY, Chan AYN, Mruk DD, Lee WM, Cheng CY (2010) Restricted Arp3 expression in the testis prevents blood-testis barrier disruption during junction restructuring at spermatogenesis. Proc Natl Acad Sci USA 107:11411-11416
129. Goley ED, Welch MD (2006) The ARP2/3 complex: an actin nucleator comes of age. Nat Rev Mol Cell Biol 7:713-726 (Pubitemid 44450456)
130. Disanza A, Carlier MF, Stradal TEB, Didry D, Frittoli E, Confalonieri S, Croce A, Wehland J, Di Fiore PP, Scita G (2004) Eps8 controls actin-based motility by capping the barbed ends of actin filaments. Nat Cell Biol 6:1180-1188 (Pubitemid 39625116)
131. Disanza A, Mantoani S, Hertzog M, Gerboth S, Frittoli E, Steffen A, Berhoerster K, Kreienkamp H, Milanesi F, Di Fiore PP, Ciliberto A, Stradal TEB, Scita G (2006) Regulation of cell shape by Cdc42 is mediated by the synergic actin-bundling activity of the Eps8-IRSp53 complex. Nat Cell Biol 8:1337-1347 (Pubitemid 44835108)
132. Lie PPY, Mruk DD, Lee WM, Cheng CY (2010) Cytoskeletal dynamics and spermatogenesis. Philos Trans R Soc Lond B Biol Sci 365:1581-1592
133. Vogl AW, Vaid KS, Guttman J (2008) The Sertoli cell cytoskeleton. In Cheng CY (ed) Molecular mechanisms in spermatogenesis. Landes Bioscience/Springer Science ? Business Media LLC, Austin, pp 186-221
134. Mruk DD, Silvestrini B, Cheng CY (2008) Anchoring junctions as drug targets: role in contraceptive development. Pharmacol Rev 60:146-180 (Pubitemid 351962007)
135. Yan HHN, Mruk DD, Lee WM, Cheng CY (2008) Blood-testis barrier dynamics are regulated by testosterone and cytokines via their differential effects on the kinetics of protein endocytosis and recycling in Sertoli cells. FASEB J 22:1945-1959 (Pubitemid 351811471)
136. Su L, Mruk DD, Lee WM, Cheng CY (2010) Differential effects of testosterone and TGF-b3 on endocytic vesicle-mediated protein trafficking events at the blood-testis barrier. Exp Cell Res 316:2945-2960
137. Russell LD (1979) Further observations on tubulobulbar complexes formed by late spermatids and Sertoli cells in rat testis. Anat Rec 194:213-232 (Pubitemid 9172804)
138. Guttman J, Takai Y, VoglAW(2004) Evidence that tubulobulbar complexes in the seminiferous epithelium are involved with internalization of adhesion junctions. Biol Reprod 71:548-559 (Pubitemid 38970532)
139. Vaid KS, Guttman JA, Babyak N, Deng W, McNiven MA, Mochizuki N, Finlay BB, Vogl AW (2007) The role of dynamin 3 in the testis. J Cell Physiol 210:644-654 (Pubitemid 46185034)
140. Young JS, Guttman JA, Vaid KS, Vogl AW (2009) Cortactin (CTTN), N-WASP (WASL), and clathrin (CLTC) are present at podosome-like tubulobulbar complexes in the rat testis. Biol Reprod 80:153-161
141. Chapin RE, Wine RN, Harris MW, Borchers CH, Haseman JK (2001) Structure and control of a cell-cell adhesion complex associated with spermiation in rat seminiferous epithelium. J Androl 22:1030-1052 (Pubitemid 33020325)
142. Guttman JA, Obinata T, Shima J, Griswold M, Vogl AW (2004) Non-muscle cofilin is a component of tubulobulbar complexes in the testis. Biol Reprod 70:805-812 (Pubitemid 38233720)
143. Kaksonen M, Toret CP, Drubin DG (2006) Harnessing actin dynamics for clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 7:404-414 (Pubitemid 44050094)
144. Xia W, Wong EWP, Mruk DD, Cheng CY (2009) TGF-b3 and TNFa perturb blood-testis barrier (BTB) dynamics by accelerating the clathrin-mediated endocytosis of integral membrane proteins: a new concept of BTB regulation during spermatogenesis. Dev Biol 327:48-61
145. Siu MKY, Lee WM, Cheng CY (2003) The interplay of collagen IV, tumor necrosis factor-a, gelatinase B (matrix metalloprotease-9), and tissue inhibitor of metalloproteases-1 in the basal lamina regulates Sertoli cell-tight junction dynamics in the rat testis. Endocrinology 144:371-387 (Pubitemid 36076127)
146. Xia W, Cheng CY (2005) TGF-b3 regulates anchoring junction dynamics in the seminiferous epithelium of the rat testis via the Ras/ERK signaling pathway: an in vivo study. Dev Biol 280:321-343 (Pubitemid 40692135)
147. Xia W, Mruk DD, Lee WM, Cheng CY (2006) Differential interactions between transforming growth factor-b3/TbR1, TAB 1, and CD2AP disrupt blood-testis barrier and Sertoli-germ cell adhesion. J Biol Chem 281:16799-16813
148. Wang Y, Lui WY (2009) Opposite effects of interleukin-1a and transforming growth factor-b2 induce stage-specific regulation of junctional adhesion molecule-B gene in Sertoli cells. Endocrinology 150:2404-2412
149. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, Nishihara M, Takahashi M, Iwakura Y (1998) Production of mice deficient in genes for interleukin (IL)-1a, Il-1b, IL-1a/b and IL-1 receptor antagonist shows that IL-1b is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 187:1463-1475 (Pubitemid 28215405)